| The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic E Kadosh, I Snir-Alkalay, A Venkatachalam, S May, A Lasry, E Elyada, ... Nature 586 (7827), 133-138, 2020 | 246 | 2020 |
| Small molecules co-targeting CKIα and the transcriptional kinases CDK7/9 control AML in preclinical models W Minzel, A Venkatachalam, A Fink, E Hung, G Brachya, I Burstain, ... Cell 175 (1), 171-185. e25, 2018 | 121 | 2018 |
| Atypical profiles and modulations of heme-enzymes catalyzed outcomes by low amounts of diverse additives suggest diffusible radicals' obligatory involvement in such redox reactions KM Manoj, A Parashar, A Venkatachalam, S Goyal, S Moharana, ... Biochimie, 2016 | 63 | 2016 |
| Functioning of Microsomal Cytochrome P450s: Murburn Concept Explains the Metabolism of Xenobiotics in Hepatocytes KM Manoj, A Parashar, SK Gade, A Venkatachalam Frontiers in pharmacology 7, 161, 2016 | 59 | 2016 |
| Electron transfer amongst flavo-and hemo-proteins: diffusible species effect the relay processes, not protein–protein binding KM Manoj, SK Gade, A Venkatachalam, DA Gideon RSC advances 6 (29), 24121-24129, 2016 | 53 | 2016 |
| Cyanide does more to inhibit heme enzymes, than merely serving as an active-site ligand A Parashar, A Venkatachalam, DA Gideon, KM Manoj Biochemical and biophysical research communications 455 (3-4), 190-193, 2014 | 50 | 2014 |
| Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme ‘active site’ pocket plays a relatively … A Venkatachalam, A Parashar, KM Manoj In Silico Pharmacology 4, 1-38, 2016 | 45 | 2016 |
| Metabolism of xenobiotics by cytochrome P450: novel insights into the thermodynamics, kinetics and roles of redox proteins and diffusible reactive species KM Manoj, A Venkatachalam, A Parashar Drug metabolism reviews 48, 41-42, 2016 | 23 | 2016 |
| Putative homeostatic role of cancer driver mutations A Venkatachalam, E Pikarsky, Y Ben-Neriah Trends in Cell Biology 32 (1), 8-17, 2022 | 5 | 2022 |
| Bioavailable dual-protein degraders of CK1α and transcriptional kinase CDK9 as potential therapeutics for hematological malignancies L Fung, AH Chourasia, E Torres, I Lam, P Erdman, D Hecht, R Sullivan, ... Blood 134, 4643, 2019 | 3 | 2019 |
| Pyrazole compounds and uses thereof D Li, I Snir-Alkalay, J Vacca, Y Ben-Neriah, A Venkatachalam US Patent 11,072,599, 2021 | 1 | 2021 |
| Tissue-Predisposition to Cancer Driver Mutations L Peters, A Venkatachalam, Y Ben-Neriah Cells 13 (2), 106, 2024 | | 2024 |
Ben-Neriah, YHebrew UniversityVerified email at ekmd.huji.ac.il
